Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoRapid 70 Mix vs NovoRapid 30 Mix in Type 2 Diabetes
NCT00318786Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2006
- Primary completion
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2006; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00318786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318786.